SlideShare una empresa de Scribd logo
1 de 78
This presentation is compiled by “ Drug Regulations” a
non profit organization which provides free online
resource to the Pharmaceutical Professional.
Visit http://www.drugregulations.org for latest
information from the world of Pharmaceuticals.

1/9/2014

1
This presentation is compiled from freely
available resources like the websites of FDA,
EMA, WHO.
 “Drug Regulations” is a non profit
organization which provides free online
resource to the Pharmaceutical Professional.
 Visit http://www.drugregulations.org for
latest information from the world of
Pharmaceuticals.


Drug Regulations : Online
Resource for Latest Information

1/9/2014

2


This presentation describes approaches for software validation used
to automate laboratory research procedures, consolidate data

collection

and

analysis

and/or

run

sophisticated

QC

or

manufacturing operations.


Several approaches to software validation exist and may be
appropriate for a specific project.



The scope of any validation effort depends upon a number of factors



Origin of the software (custom vs. off-the-shelf) and





Size and complexity of the software,
Whether the functions are critical or non-critical in nature.

By effectively planning the process, validation time and resources
can be reduced while meeting regulatory requirements.
Drug Regulations : Online Resource for Latest
Information
1/9/2014

3


When equipment breaks, there are typically obvious and immediate
symptoms. Catastrophic results can often be avoided



Computer system defects can typically be very difficult to recognise
and severe problems may result without being detected until well
after the problem started



Drug companies, the airline industry, public utilities, nuclear power
plants and other industries where quality is critical have seen very
expensive consequences from improper computer system operation



Many of these consequences cost far more than the cost of
Computer Validation
Drug Regulations : Online Resource for Latest
Information
1/9/2014

4


Significant increase in the use of computer-

related systems in the Life Sciences industries.


These systems must satisfy cGMP requirements



Legitimate questions have been raised

concerning the scope and methods which should
be employed in validations.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

5


Responsibility of the end-user to assure that

systems

used

are

in

compliance

with

applicable regulations.


Many users rely too heavily upon vendorsupplied information and test data to support
their system validation.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

6


The extent of testing and the type of documentation

required to support validation is unclear


Difficult to delineate vendor and user responsibilities
when validating vendor-supplied systems.



Validation of computer-related systems is often
complex, and any number of alternate approaches
can be utilized.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

7
In general, a combination of hardware, software,
people, documents, inputs, processing, and outputs
working together

Inputs

Software

Hardware

Controlling System
Controlled process

outputs

Equipment
Operating Procedures &
Documentation
People and Training

Drug Regulations : Online Resource for Latest
Information
• MRP/ERP system?

• LIMS system?
• Laboratory Instruments (e.g. Chromatography)?
• Automated manufacturing or packaging equipment?

• IT systems, including those supporting network and
infrastructure?
• Spreadsheets or databases?

Drug Regulations : Online Resource for Latest
Information
1/9/2014

9


FDA approach is based on three main elements: (Guidance)
◦ Part 11 will be interpreted narrowly

◦ Fewer records subject to part 11
◦ For those records that remain subject to part 11, FDA intends to exercise
enforcement discretion with regard to part 11 requirements for
 Validation
 Audit trails

 Record retention
 Record copying


Systems that were operational before the effective date of part
11 (also known as legacy systems)
◦ FDA will enforce all predicate rule requirements, including predicate rule
record and recordkeeping requirements.
Drug Regulations : Online Resource for Latest
Information
1/9/2014

10


FDA's exercise of enforcement discretion as

described in this guidance is limited to specified
part 11 requirements


FDA intends to enforce all other provisions of

part 11 including, but not limited to, certain
controls for closed systems in § 11.10.
◦ For example, FDA intends to enforce provisions related

to the following controls and requirements:
Drug Regulations : Online Resource for Latest
Information
1/9/2014

11
◦ Limiting system access to authorized individuals

◦ Use of operational system checks
◦ Use of authority checks
◦ Use of device checks

◦ Determination that persons who develop, maintain,
or use electronic systems have the education,
training, and experience to perform their assigned

tasks
Drug Regulations : Online Resource for Latest
Information
1/9/2014

12
◦ Appropriate controls over systems documentation

◦ Controls

for

open

systems

corresponding

to

controls for closed systems bulleted above (§
11.30)

◦ Requirements related to electronic signatures
 (e.g., §§ 11.50, 11.70, 11.100, 11.200, and 11.300)

Drug Regulations : Online Resource for Latest
Information
1/9/2014

13
◦ FDA intends to exercise enforcement discretion

regarding

specific

part

11

requirements

for

validation of computerized systems (§ 11.10(a) and
corresponding requirements in § 11.30).

Drug Regulations : Online Resource for Latest
Information
1/9/2014

14
◦ Take into account the impact the systems have on

ability to meet predicate rule requirements.
◦ Consider the impact those systems might have on
the accuracy, reliability, integrity, availability, and

authenticity of required records and signatures.
◦ Even if there is no predicate rule requirement to
validate a system, in some instances it may still be

important to validate the system.
Drug Regulations : Online Resource for Latest
Information
1/9/2014

15
◦ Base validation approach on
 A justified and documented risk assessment
 A determination of the potential of the system to affect
product quality and safety, and record integrity.

◦ Validation would not be important for a word
processor used only to generate SOPs.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

16


Audit Trails
◦ Enforcement discretion related to computer-generated, timestamped audit trails (§ 11.10 (e), (k)(2) and any corresponding
requirement in §11.30).
◦ Also comply with all applicable predicate rule requirements

related to documentation
 Date (e.g., § 58.130(e))
 Time, or sequencing of events
 Requirements for ensuring that changes to records do not obscure

previous entries
Drug Regulations : Online Resource for Latest
Information
1/9/2014

17


Audit Trails
◦ Have them even if there are no predicate rule
requirements
 (for date, time, or sequence of events)

◦ Alternatively

have

other

physical,

logical,

or

procedural security measures in place.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

18


Audit Trails
◦ Base your decision on
 The need to comply with predicate rule requirements
 A justified and documented risk assessment

 A determination of the potential effect on product
quality and safety and record integrity

Drug Regulations : Online Resource for Latest
Information
1/9/2014

19


Audit Trails
◦ Apply appropriate controls based on such an
assessment.
◦ Audit trails appropriate when records are
 Created
 Modified
 Deleted

Drug Regulations : Online Resource for Latest
Information
1/9/2014

20


Legacy Systems
◦ FDA to exercise enforcement discretion for systems
that otherwise were operational prior to August 20,
1997
◦ FDA not to take enforcement action if all the
following criteria are met for a specific system:

Drug Regulations : Online Resource for Latest
Information
1/9/2014

21


Legacy Systems …..contd
◦ The system was operational before the effective date.
◦ The system met all applicable predicate rule requirements before
the effective date.
◦ The

system

currently

meets

all

applicable

predicate

rule

requirements.
◦ You have documented evidence and justification that the system is
fit for its intended use (including having an acceptable level of
record security and integrity, if applicable).

Drug Regulations : Online Resource for Latest
Information
1/9/2014

22


Applies to all forms of computerised systems used as part of a
GMP regulated activities.



A computerised system is a set of software and hardware
components which together fulfil certain functionalities.



The application should be validated;



IT infrastructure should be qualified.



Where a computerised system replaces a manual operation, there
should be no resultant decrease in product quality, process
control or quality assurance.



There should be no increase in the overall risk of the process.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

23


Validation
◦ Documentation and reports should
 Cover life cycle.
 Include change control

 Deviations during validation process

◦ Justify

standards,

protocols,

acceptance

criteria, procedures and records based on their risk

assessment.
Drug Regulations : Online Resource for Latest
Information
1/9/2014

24


Validation
◦ List all relevant systems and their GMP functionality
◦ For critical systems prepare
 System description
 Physical and logical arrangements
 Data flows
 Interfaces with other systems or processes
 Hardware and software pre-requisites

 Security measures
Drug Regulations : Online Resource for Latest
Information
1/9/2014

25


Validation
◦ Prepare user requirements Specifications
 Describe the required functions
 Base it on documented risk assessment and GMP

impact
 Make it traceable throughout the life-cycle

Drug Regulations : Online Resource for Latest
Information
1/9/2014

26


Validation
◦ Ensure that the system has been

developed in

accordance with Q M S
◦ Assess the supplier appropriately

◦ Ensure formal assessment and reporting of quality
& performance measures of bespoke or customised
computerised systems for life cycle.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

27


Validation
◦ Demonstrate evidence of appropriate test methods
and test scenarios
 System (process) parameter limits

 Data limits
 Error handling

◦ Document adequacy of Automated testing tools and

test environments.
Drug Regulations : Online Resource for Latest
Information
1/9/2014

28


Validation
◦ If data are transferred to another data format or
system, validation should include checks that data
are not altered in value and/or meaning during this

migration process.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

29
New Computer System

Existing Computer System

Def inesy stem
Function Structure

Def ine Sof tware

Def inesy stem
Function Structure

Design/Specif y
hardware
Qualif y Sy stem

Dev elop
Sof tware

I ns t all hardware

Rev iew operating
experience

Verif y Sof tware

Qualif y hardware

Test Indiv idual
Modules (Computer
Sy stem)

Data

Integrate
ComputerizedSy stem

Dataanaly sis

Test Integrated
modules
(Computerized
Sy stem)

Validation
Acceptance

Demonstratetotal
sy stem operation
(Computer-Related
Sy stem)

Ongoings y s t em ev aluat ion

Change

Conduct sy stem
testing (if needed)

F ileD oc um ent at ion

1/9/2014

30


Users play a key validation role in:
 Starting the process for new or existing systems

 Performing some major steps (e.g. Requirements)
 Writing and following operating procedure
 Maintaining the validated state while in use


Developers play a key role in many steps including:
 Design, coding, testing, changes, support



Support groups (IT, IR, SCS, Infrastructure):
 Maintain proper network environment
 Troubleshooting and maintenance

 Desktop and infrastructure control

Drug Regulations : Online Resource for Latest
Information
1/9/2014

31


QA and Validation
Author some major documents
Approve major documents that others write
Provide advice, training, auditing



Senior management for each group decides:
Which systems to buy or build
How much resource to make available

What risks are acceptable
Drug Regulations : Online Resource for Latest
Information
1/9/2014

32
Incorporate multi-functional participation



◦

Management Information Systems

◦

Developers

◦

Vendors

◦

Consultants

◦

Software QA

◦

Executive Management

Drug Regulations : Online Resource for Latest
Information
1/9/2014

33
Responsibilities



◦

Definition

◦

Planning

◦

Risk Assessment

◦

Evaluation of intended use

◦

Execution

◦

Documentation

◦

Review

◦

Approval

Drug Regulations : Online Resource for Latest
Information
1/9/2014

34


Have a combination of skill sets in the team



Include individuals who are experienced with
◦

Regulations

◦

Validation approaches

◦

Systems

◦

Processes

◦

Intended users

Drug Regulations : Online Resource for Latest
Information
1/9/2014

35
The level of documentation required depends on



◦

Complexity and intended use of the system;

◦

Origin of the software/system (vendor supplied or
developed internally).

◦

Examples

of

documentation

required

to

support

validation:

Drug Regulations : Online Resource for Latest
Information
1/9/2014

36


Validation SOPs and Policies



Project Management Plan



Validation Plan



Traceability Analysis



Risk (Hazard) Management



System Topology and



Specification and Documents

Plan


Computerized System Design

Installation Summaries

Configuration Management



Plan

Validation Protocols / Test

Case Procedures



Change Management Plan



IQ/OQ/PQ Reports



System Test Plans



Validation Reports



Computer-Related System
Requirements Specification

Drug Regulations : Online Resource for Latest
Information
1/9/2014

37
1. PLAN
Validation Activities

4. DESIGN & REVIEW
5. CONSTRUCT & TEST

2. DEFINE

6. INTEGRATE/INSTALL

Requirements

7. QUALIFY
8. EVALUATE

3. SELECT

Computerized System

Vendors

Drug Regulations : Online Resource for Latest
Information


Write and approve validation policies



Write specific SOPs for validation of Computer Systems



Develop protocols



Review test data



Write summary reports to assure the validation objectives are met



Use validation Project Plan to


Identify the systems to be included



Procedures to be followed



Timeline for a specific validation project
Drug Regulations : Online Resource for Latest
Information
1/9/2014

39
 Project resources and budget requirements


Validation Project Plan for
 Single system,
 Combination of systems

 Entire facility.


Establish specific responsibilities



Establish expectations for each validation

activity
Drug Regulations : Online Resource for Latest
Information
1/9/2014

40
 Create a document of high level goals of validation

 Specify

“what”

at

a

high

level

should

be

accomplished by the CSV
 Review available documentation
 Conduct interviews with users
 Map existing processes

Drug Regulations : Online Resource for Latest
Information
1/9/2014

41
 Initial focus on
 Functionality
 Operational and performance parameters
 Overall objectives for the validation effort

 Specify the requirement in detail to support testing
that requirement and defining acceptance criteria.
 Trace back protocols to each requirement
 via a Traceability Matrix
Drug Regulations : Online Resource for Latest
Information
1/9/2014

42
 Requirements traceable to Functional Specifications

and testing
 Unambiguous, clear, concise
 Testable and measurable

 Typically written and approved by end-user
 Basis for system acceptance testing
 Should be approved before the design review

Drug Regulations : Online Resource for Latest
Information
1/9/2014

43
 The highest level design document responding

directly to the User Requirements Specification
 All system inputs, outputs, and interfaces
 All functions and performance requirements

 Error definition and handling
 Ranges, limits, defaults
 Safety considerations

Drug Regulations : Online Resource for Latest
Information
1/9/2014

44
 Internal development group or an outside company.
 Consider vendor‟s ability to provide a system which can
be validated
 Selection Criteria
 Technical competency
 Qualified to supply
 Support for the proposed system
 Knowledge of validation requirements
 Experience in providing systems for cGMP applications
Drug Regulations : Online Resource for Latest
Information
1/9/2014

45
 Type of software being evaluated
 Type hardware being evaluated

 For off-the-shelf software and standard hardware
 History of customer satisfaction is of importance

 For custom developed systems
 Vendor‟s Quality Assurance System

Drug Regulations : Online Resource for Latest
Information
1/9/2014

46
Primary Responsibility
for Specification

Primary Responsibility
for Testing
Testing of the URS

More User involvement for custom
systems, less for packaged
Supplier

Functional
Specification

Performance
Qualification

Testing of the
Functional Specification

Design
Specification

Testing of the

Operation
Qualification

Installation
Qualification

Design Specification

Build System

Design
Specification

Unit Testing

Requirement Specification

System Testing

Drug Regulations : Online Resource for Latest
Information

User
More Supplier involvement for custom
systems, less for packaged

User Requirements
Specification

User

Supplier
 Computerized System Design Specification
 Document or a collection of documents
 Describes clearly and completely
 How the computerized system will Operate
 Satisfy Computer-Related System Requirements
Specification
 Both normal and abnormal operating conditions
 Information about the interfaces between the

computerized system and its operating environment
Drug Regulations : Online Resource for Latest
Information
1/9/2014

48
 Applies to both the computer system and the controlled
function/process
 joint responsibility of the vendor and user.
 Interfaces between the computerized system and its
operating environment.

 The Design Specification can not be developed until
the vendors and the specific hardware and software
have been selected.
Drug Regulations : Online Resource for Latest
Information
1/9/2014

49
 Defines how the system should meet the
requirements, including…
 Architecture AND interfaces
 All functions
 Data processing and integrity
 Security
 Backup, archive, and restoration
 disaster recovery

 Data definition
Drug Regulations : Online Resource for Latest
Information
1/9/2014

50
 Activity performed to verify that all deliverables

from Requirements and Design Phases are
produced and…
 are clear and concise

 are complete, current, and traceable
 electronic record and signatures addressed
 are testable

 show system fit for purpose
Drug Regulations : Online Resource for Latest
Information
1/9/2014

51
 Complete Design Review before starting

 Perform in accordance with written Programming
Standards
 Programming Standards should define appropriate
rules for writing source code (e.g. dead code,
structure, naming)

Drug Regulations : Online Resource for Latest
Information
1/9/2014

52
 The computerized system may be constructed by
developing custom software and hardware for the
application - or purchasing established products - or a
combination of both.

 From a validation perspective, custom developed
software and hardware require the greatest amount of
testing since they have never been proven effective.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

53
 Three categories of software can be defined:
 System software
 Configurable software
 Application specific software

Drug Regulations : Online Resource for Latest
Information
1/9/2014

54
GAMP Classification
No

GAMP 4

GAMP 5

1

Operating Systems

Infrastructure Software

2

Firmware

No longer used

3

Standard Software Packages

Non configured Products

4

Configurable Software
Packages

Configured Products

5

Custom (bespoke) Software

Custom Applications

Drug Regulations : Online Resource for Latest
Information
1/9/2014

55
 These categories are not intended to be rigid but

they allow distinctions to be made so that
validation approaches are appropriate.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

56
 Efficient Environment
 Defined processes
 Assigned responsibilities
 Planned audits

 Structured reviews
 Management controls

Drug Regulations : Online Resource for Latest
Information
1/9/2014

57
 Should be completed before formal testing

 Verify code complies with Programming Standards
 Check to ensure all pre-defined system
specifications are addressed
 Check for coding errors

Drug Regulations : Online Resource for Latest
Information
1/9/2014

58
„White Box‟ *
●

Unit Testing/Structural Testing

●

Low level

out

in

„Black Box‟ *
●

System & Acceptance testing

●

Functional Testing

●

Higher level
in

out

Manual Calculation

Drug Regulations : Online Resource for Latest
Information
 Define and justify the how the system will be

tested and how much
 Address how tests are traceable to specifications
 Testing approach should address
 Normal operation
 Entire design range, boundaries, stress
 Failure modes, including power failure

 Should be approved before testing starts
Drug Regulations : Online Resource for Latest
Information
1/9/2014

60
 Lists the test objective

 Traceable to specifications
 Lists test pre-requisites
 Reproducible test steps
 Clear acceptance criteria

Drug Regulations : Online Resource for Latest
Information
1/9/2014

61
 Record all raw data and derived results
 Ticks, „ok‟, „yes/no‟, „Pass/Fail‟ or similar are not valid
results
 Record a „Pass/Fail‟ conclusion of whether results met

acceptance criteria
 Signature and date of test performer
 Signature and date of test result approver

 References to incident log for failures
Drug Regulations : Online Resource for Latest
Information
1/9/2014

62
 Used to…
 Collate test result documentation
 Conclude each phase of testing
 Authorise subsequent testing phases

 Summarises the testing outcome, addresses test
failures

Drug Regulations : Online Resource for Latest
Information
1/9/2014

63
 Unit Testing
 Focuses verification effort on the smallest unit of software
design – the software component or module

 Integration Testing
 “If they all work individually, why do you doubt that they‟ll work
when we put them together?”
 The problem is “putting them together” – interfacing

 Data may be lost
 One module can have an inadvertent, adverse effect on
another; sub-function when combined
 Global data structure can present problems

Drug Regulations : Online Resource for Latest
Information
1/9/2014

64


Regression Testing
 Each time a new module is added as part of integration
testing, the software changes
 New data flow paths are established
 New I/O and control logic is invoked
 Regression testing is the re-execution of some subset of tests
that have already been conducted to ensure that changes have
not propagated unintended side effects

Drug Regulations : Online Resource for Latest
Information
1/9/2014

65


Smoke testing
 An integration testing
 Software components that have been translated into code are
integrated into a “build” – data files, libraries, reusable modules,
and engineered components that are required to implement one
or more product
 The intent of testing here is to uncover show stoppers – errors
that have the highest likelihood of throwing the software project
behind schedule
 The build is integrated with other builds and the entire product is
smoke tested daily
Drug Regulations : Online Resource for Latest
Information
1/9/2014

66


Unit Testing





An encapsulated class is the focus of unit testing

Operations within the class are, however, the smallest unit

Integration Testing


Thread based testing



Integrates a set of classes required to respond to one input or event for the
system



Used based testing


Begins the construction of the system by testing independent classes – use
very few if any server classes



Testing dependent classes – which use independent classes

Drug Regulations : Online Resource for Latest
Information
1/9/2014

67


Integration Testing
 Cluster Testing
 A cluster of collaborating classes (determined by
examining the CRC) to uncover errors in
collaboration

Drug Regulations : Online Resource for Latest
Information
1/9/2014

68
 Proper integration, installation and commissioning

of a computerized system is essential to the
successful qualification of the system.
 A packaged system may be integrated at the
vendors site
 More complex systems may be integrated at the

users site
Drug Regulations : Online Resource for Latest
Information
1/9/2014

69
 Data Load
 Operational and Support Plans (e.g.
SOP, training, service contracts, security, support
processes)

 Specify procedures employed in the Validation Plan.
 Specify responsibility for all tasks in the Validation Plan.
 Demonstrate proper installation of hardware & software

in Installation Qualification (IQ)
Drug Regulations : Online Resource for Latest
Information
1/9/2014

70
 Qualification is a procedure of testing and collecting data
to provide a high level of assurance that a computerized
system operates in accordance with the system
specification.
 Write & approve protocols in advance

 Protocols should specify the following
 Goals of testing
 Test methods
 Acceptance criteria
 Who is responsible for testing
Drug Regulations : Online Resource for Latest
Information
1/9/2014

71
 IQ (Installation Qualification) verifies that all aspects of
installing hardware and software meet specifications
and that user manuals, SOP‟s and backup procedures
are in place.

 OQ (Operational Qualification) verifies that the system
operates throughout its anticipated ranges according to
its specifications and identifies all important

parameters.
Drug Regulations : Online Resource for Latest
Information
1/9/2014

72
 PQ (Performance Qualification) verifies that a

system performs its intended function in
accordance with its specifications.
 Testing is completed on the entire system while
operating in its normal environment.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

73
 In order to assure that the system remains in a validated state,
Performance Monitoring is required to continually test a system‟s
performance in executing defined processes:


Periodic calibration and maintenance



Continuous monitoring of critical parameters



Confirmation of security measures



Provisions for contingency planning, disaster recovery and personnel
training

 Change Control procedures must be established to keep a CRS in
a validated state during planned and unplanned changes.

Drug Regulations : Online Resource for Latest
Information
1/9/2014

74
Summary: Validation requirements for Software

Programme
overrides

Edits,
input
manipulation

Language

Name,
function

Software
identification

Fixed and
Variable
Set points

Input,
output

Drug Regulations : Online Resource for Latest
Information
Summary: Validation requirements for Software

Key aspects

Software
development

Software
security

Drug Regulations : Online Resource for Latest
Information
Summary: Validation requirements for Software

Function

Worst case

Documentation

Validation

Revalidation
Repeats

Drug Regulations : Online Resource for Latest
Information


This presentation was compiled from freely
available resources like the websites of FDA,
EMA, WHO.
 “Drug Regulations” is a non profit
organization which provides free online
resource to the Pharmaceutical Professional.
 Visit http://www.drugregulations.org for
latest information from the world of
Pharmaceuticals.
Drug Regulations : Online
Resource for Latest Information

1/9/2014

78

Más contenido relacionado

La actualidad más candente

Computer system validation
Computer system validation Computer system validation
Computer system validation ShameerAbid
 
Computerized system validation_final
Computerized system validation_finalComputerized system validation_final
Computerized system validation_finalDuy Tan Geek
 
Overview of computer system validation
Overview of computer system validationOverview of computer system validation
Overview of computer system validationNilesh Damale
 
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 GuideOverview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 GuideProPharma Group
 
Six system inspection model.
Six system inspection model.Six system inspection model.
Six system inspection model.VikramMadane1
 
Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing PracticesPrashant Tomar
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validationBangaluru
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection modelVaishali Dandge
 
Batch Review And Batch Release.pptx
Batch Review And Batch Release.pptxBatch Review And Batch Release.pptx
Batch Review And Batch Release.pptxAbhishekJadhav189260
 
Ensuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environmentEnsuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environmentdeepak mishra
 
21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11Rohit K.
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviationDr. Amsavel A
 
Auditing of quality assurance and maintenance of engineering department
Auditing of quality assurance and   maintenance of engineering departmentAuditing of quality assurance and   maintenance of engineering department
Auditing of quality assurance and maintenance of engineering departmentPriyanka Kandhare
 

La actualidad más candente (20)

Gamp5 new
Gamp5 newGamp5 new
Gamp5 new
 
21 code of federal regulation
21 code of federal regulation21 code of federal regulation
21 code of federal regulation
 
ALCOA & ALCOA+
ALCOA & ALCOA+ALCOA & ALCOA+
ALCOA & ALCOA+
 
Computer system validation
Computer system validation Computer system validation
Computer system validation
 
Computerized system validation_final
Computerized system validation_finalComputerized system validation_final
Computerized system validation_final
 
Overview of computer system validation
Overview of computer system validationOverview of computer system validation
Overview of computer system validation
 
21 CFR part 11 Overview
21 CFR part 11 Overview21 CFR part 11 Overview
21 CFR part 11 Overview
 
Cfr 21 part 11
 Cfr 21 part 11 Cfr 21 part 11
Cfr 21 part 11
 
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 GuideOverview of Computerized Systems Compliance Using the GAMP® 5 Guide
Overview of Computerized Systems Compliance Using the GAMP® 5 Guide
 
Six system inspection model.
Six system inspection model.Six system inspection model.
Six system inspection model.
 
Good Automated Manufacturing Practices
Good Automated Manufacturing PracticesGood Automated Manufacturing Practices
Good Automated Manufacturing Practices
 
Risk assessment for computer system validation
Risk assessment for computer system validationRisk assessment for computer system validation
Risk assessment for computer system validation
 
Pharmaceutical Qualification & Validation
Pharmaceutical Qualification & ValidationPharmaceutical Qualification & Validation
Pharmaceutical Qualification & Validation
 
FDA 483 observations in the lab
FDA 483 observations in the labFDA 483 observations in the lab
FDA 483 observations in the lab
 
Six system inspection model
Six system inspection modelSix system inspection model
Six system inspection model
 
Batch Review And Batch Release.pptx
Batch Review And Batch Release.pptxBatch Review And Batch Release.pptx
Batch Review And Batch Release.pptx
 
Ensuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environmentEnsuring data integrity in pharmaceutical environment
Ensuring data integrity in pharmaceutical environment
 
21 cfr part 11
21 cfr part 1121 cfr part 11
21 cfr part 11
 
GMP Training: Handling of deviation
GMP Training: Handling of deviationGMP Training: Handling of deviation
GMP Training: Handling of deviation
 
Auditing of quality assurance and maintenance of engineering department
Auditing of quality assurance and   maintenance of engineering departmentAuditing of quality assurance and   maintenance of engineering department
Auditing of quality assurance and maintenance of engineering department
 

Destacado

computer system validation
computer system validationcomputer system validation
computer system validationGopal Patel
 
Codex validation Group presentation
Codex validation Group presentationCodex validation Group presentation
Codex validation Group presentationWalter Acevedo
 
Computer system validation
Computer system validationComputer system validation
Computer system validationGaurav Kr
 
IT Validation Training
IT Validation TrainingIT Validation Training
IT Validation TrainingRobert Sturm
 
Concept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQConcept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQdhavalrock24
 
Computer System Validation is not mere testing
Computer System Validation is not mere testingComputer System Validation is not mere testing
Computer System Validation is not mere testingAnand Rao. C
 
FDA/EC/WHO Expectations for Computer System Validation
FDA/EC/WHO Expectations for Computer System Validation FDA/EC/WHO Expectations for Computer System Validation
FDA/EC/WHO Expectations for Computer System Validation Muhammad Luqman Ikram
 
Computer System Validation Training
Computer System Validation TrainingComputer System Validation Training
Computer System Validation TrainingNetZealous LLC
 
CSV Audit Presentation
CSV Audit PresentationCSV Audit Presentation
CSV Audit PresentationRobert Ruemer
 
Equipment validation of fbd
Equipment validation of fbdEquipment validation of fbd
Equipment validation of fbdpriyanka odela
 
Computer system validation
Computer system validationComputer system validation
Computer system validationNitor Infotech
 
"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”
"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”
"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”Marcep Inc.
 
Cleaning validation a complete know how
Cleaning validation a complete know howCleaning validation a complete know how
Cleaning validation a complete know howSambhujyoti Das
 
Vish- Validation Master Plan
Vish- Validation Master PlanVish- Validation Master Plan
Vish- Validation Master PlanVishal Parikh
 

Destacado (20)

computer system validation
computer system validationcomputer system validation
computer system validation
 
Codex validation Group presentation
Codex validation Group presentationCodex validation Group presentation
Codex validation Group presentation
 
Computer system validation
Computer system validationComputer system validation
Computer system validation
 
IT Validation Training
IT Validation TrainingIT Validation Training
IT Validation Training
 
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation Correlation  of  FDA-EU-PICS-WHO Requirement for Computer System Validation
Correlation of FDA-EU-PICS-WHO Requirement for Computer System Validation
 
Concept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQConcept of URS,DQ,IQ,OQ,PQ
Concept of URS,DQ,IQ,OQ,PQ
 
Computer systems compliance
Computer systems complianceComputer systems compliance
Computer systems compliance
 
Computer System Validation is not mere testing
Computer System Validation is not mere testingComputer System Validation is not mere testing
Computer System Validation is not mere testing
 
PROCESS VALIDATION
PROCESS VALIDATIONPROCESS VALIDATION
PROCESS VALIDATION
 
FDA/EC/WHO Expectations for Computer System Validation
FDA/EC/WHO Expectations for Computer System Validation FDA/EC/WHO Expectations for Computer System Validation
FDA/EC/WHO Expectations for Computer System Validation
 
Computer System Validation Training
Computer System Validation TrainingComputer System Validation Training
Computer System Validation Training
 
Good Practices for Computerised Systems : PIC/S Guidance
Good Practices for Computerised Systems : PIC/S GuidanceGood Practices for Computerised Systems : PIC/S Guidance
Good Practices for Computerised Systems : PIC/S Guidance
 
New WHO Guidance on CS Validation
New WHO Guidance on CS ValidationNew WHO Guidance on CS Validation
New WHO Guidance on CS Validation
 
CSV Audit Presentation
CSV Audit PresentationCSV Audit Presentation
CSV Audit Presentation
 
Equipment validation of fbd
Equipment validation of fbdEquipment validation of fbd
Equipment validation of fbd
 
Computer system validation
Computer system validationComputer system validation
Computer system validation
 
"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”
"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”
"GAMP 5 & 21 CFR Part 11 Compliance with Computer System Validation”
 
Cleaning validation a complete know how
Cleaning validation a complete know howCleaning validation a complete know how
Cleaning validation a complete know how
 
New EU Requirements for Qualification & Validation
New EU Requirements for Qualification & ValidationNew EU Requirements for Qualification & Validation
New EU Requirements for Qualification & Validation
 
Vish- Validation Master Plan
Vish- Validation Master PlanVish- Validation Master Plan
Vish- Validation Master Plan
 

Similar a Computer System Validation

computers in clinical development
 computers in clinical development computers in clinical development
computers in clinical developmentSUJITHA MARY
 
Data Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in PharmaData Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in PharmaSathish Vemula
 
A GAMP Approach to Data Integrity, Electronic Records & Signatures & Operati...
A GAMP Approach to Data Integrity, Electronic Records & Signatures &  Operati...A GAMP Approach to Data Integrity, Electronic Records & Signatures &  Operati...
A GAMP Approach to Data Integrity, Electronic Records & Signatures & Operati...sazalsutra
 
Computer system validation review article by-mahesh b wazade
Computer system validation review article by-mahesh b wazadeComputer system validation review article by-mahesh b wazade
Computer system validation review article by-mahesh b wazadeMahesh B. Wazade
 
Analytical Instrument Qualification and System Validation
Analytical Instrument Qualification and System ValidationAnalytical Instrument Qualification and System Validation
Analytical Instrument Qualification and System ValidationComplianceOnline
 
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceComputer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceGreenlight Guru
 
Presentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustryPresentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustrySathish Vemula
 

Similar a Computer System Validation (20)

New WHO Guidance on Process Validation
New WHO Guidance on Process ValidationNew WHO Guidance on Process Validation
New WHO Guidance on Process Validation
 
computers in clinical development
 computers in clinical development computers in clinical development
computers in clinical development
 
FDA Guidance on Facing Manufacturing Inspections
FDA Guidance on Facing Manufacturing InspectionsFDA Guidance on Facing Manufacturing Inspections
FDA Guidance on Facing Manufacturing Inspections
 
Data Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in PharmaData Integrity II - Chromatography data system (CDS) in Pharma
Data Integrity II - Chromatography data system (CDS) in Pharma
 
Data integrity
Data integrityData integrity
Data integrity
 
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EUQ&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
Q&A về quy định quản lý hệ thống vi tính theo tiêu chuẩn GMP EU
 
Data Integrity in FDA Regulated Labs
Data Integrity in FDA Regulated LabsData Integrity in FDA Regulated Labs
Data Integrity in FDA Regulated Labs
 
EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements EMA Qualification & Validation Requirements
EMA Qualification & Validation Requirements
 
A GAMP Approach to Data Integrity, Electronic Records & Signatures & Operati...
A GAMP Approach to Data Integrity, Electronic Records & Signatures &  Operati...A GAMP Approach to Data Integrity, Electronic Records & Signatures &  Operati...
A GAMP Approach to Data Integrity, Electronic Records & Signatures & Operati...
 
Qb d agency expectations
Qb d agency expectationsQb d agency expectations
Qb d agency expectations
 
FDA Guidance on Facing Sterile Manufacturing Inspections.
FDA Guidance on Facing Sterile Manufacturing  Inspections.FDA Guidance on Facing Sterile Manufacturing  Inspections.
FDA Guidance on Facing Sterile Manufacturing Inspections.
 
US FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process VerificationUS FDA Process Validation Stage 3: Continued Process Verification
US FDA Process Validation Stage 3: Continued Process Verification
 
GMP's as per US FDA Part I
GMP's as per US FDA Part IGMP's as per US FDA Part I
GMP's as per US FDA Part I
 
Validation
Validation Validation
Validation
 
P rocess validation 1
P rocess validation 1P rocess validation 1
P rocess validation 1
 
Computer system validation review article by-mahesh b wazade
Computer system validation review article by-mahesh b wazadeComputer system validation review article by-mahesh b wazade
Computer system validation review article by-mahesh b wazade
 
Analytical Instrument Qualification and System Validation
Analytical Instrument Qualification and System ValidationAnalytical Instrument Qualification and System Validation
Analytical Instrument Qualification and System Validation
 
Phụ lục 11 GMPEU. Hệ thống máy tính
Phụ lục 11 GMPEU. Hệ thống máy tínhPhụ lục 11 GMPEU. Hệ thống máy tính
Phụ lục 11 GMPEU. Hệ thống máy tính
 
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft GuidanceComputer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
Computer Software Assurance (CSA): Understanding the FDA’s New Draft Guidance
 
Presentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical IndustryPresentation on data integrity in Pharmaceutical Industry
Presentation on data integrity in Pharmaceutical Industry
 

Más de GMP EDUCATION : Not for Profit Organization

Más de GMP EDUCATION : Not for Profit Organization (20)

Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.Risk Assessment for Control of Elemental Impurities.
Risk Assessment for Control of Elemental Impurities.
 
Pharmaceutical Quality System
Pharmaceutical Quality System Pharmaceutical Quality System
Pharmaceutical Quality System
 
New WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method ValidationNew WHO Guidance on Analytical Method Validation
New WHO Guidance on Analytical Method Validation
 
Blend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way ForwardBlend and Content Uniformity : Industry Recommendations for Way Forward
Blend and Content Uniformity : Industry Recommendations for Way Forward
 
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
Content Uniformity and Blend Uniformity : Why FDA Withdrew the 2002 Guidance
 
WHO Guidance on Preparation of Laboratory Information File
WHO  Guidance on Preparation of Laboratory Information FileWHO  Guidance on Preparation of Laboratory Information File
WHO Guidance on Preparation of Laboratory Information File
 
US FDA Quality Metrics Technical Conformance Guide
US FDA  Quality Metrics Technical  Conformance GuideUS FDA  Quality Metrics Technical  Conformance Guide
US FDA Quality Metrics Technical Conformance Guide
 
Calculation of Risk Priority Numbar
Calculation of  Risk Priority NumbarCalculation of  Risk Priority Numbar
Calculation of Risk Priority Numbar
 
New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.New PICS Guidance on Data Integrity and Management.
New PICS Guidance on Data Integrity and Management.
 
ASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and QualificationsASTM Standard E 2500 for Commissioning and Qualifications
ASTM Standard E 2500 for Commissioning and Qualifications
 
US FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ BatchesUS FDA - EU Process Validation : Determination of Number of PPQ Batches
US FDA - EU Process Validation : Determination of Number of PPQ Batches
 
Presentation on US FDA Data Integrity Guidance.
Presentation on US FDA  Data Integrity Guidance.Presentation on US FDA  Data Integrity Guidance.
Presentation on US FDA Data Integrity Guidance.
 
Quality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental MonitoringQuality Risk Assessmsnt for Environmental Monitoring
Quality Risk Assessmsnt for Environmental Monitoring
 
Understanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room ContaminationUnderstanding and Preventing Clean Room Contamination
Understanding and Preventing Clean Room Contamination
 
Process Validation of Legacy Products
Process Validation of Legacy ProductsProcess Validation of Legacy Products
Process Validation of Legacy Products
 
WHO Guidance on Technology Transfers
WHO Guidance on Technology TransfersWHO Guidance on Technology Transfers
WHO Guidance on Technology Transfers
 
Who Guidelines for Preparing SMF
Who Guidelines for Preparing  SMFWho Guidelines for Preparing  SMF
Who Guidelines for Preparing SMF
 
Validation of Microbiological Methods
Validation of Microbiological MethodsValidation of Microbiological Methods
Validation of Microbiological Methods
 
Presentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QPPresentation on EU GMP Annex 16 - Certification by QP
Presentation on EU GMP Annex 16 - Certification by QP
 
WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.WHO Good Practices for Microbiology Labs.
WHO Good Practices for Microbiology Labs.
 

Último

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsMedicoseAcademics
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfMedicoseAcademics
 
High Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near Me
High Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near MeHigh Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near Me
High Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near Menarwatsonia7
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknownarwatsonia7
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipurparulsinha
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photosnarwatsonia7
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...Ahmedabad Escorts
 
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls ServiceCall Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Servicesonalikaur4
 
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAAjennyeacort
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.ANJALI
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxNiranjan Chavan
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️saminamagar
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Availablenarwatsonia7
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxDr.Nusrat Tariq
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptxDr.Nusrat Tariq
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...narwatsonia7
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...narwatsonia7
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowNehru place Escorts
 

Último (20)

Hematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes FunctionsHematology and Immunology - Leukocytes Functions
Hematology and Immunology - Leukocytes Functions
 
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdfHemostasis Physiology and Clinical correlations by Dr Faiza.pdf
Hemostasis Physiology and Clinical correlations by Dr Faiza.pdf
 
High Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near Me
High Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near MeHigh Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near Me
High Profile Call Girls Mavalli - 7001305949 | 24x7 Service Available Near Me
 
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service LucknowVIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
VIP Call Girls Lucknow Nandini 7001305949 Independent Escort Service Lucknow
 
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service JaipurHigh Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
High Profile Call Girls Jaipur Vani 8445551418 Independent Escort Service Jaipur
 
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original PhotosBook Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
Book Call Girls in Yelahanka - For 7001305949 Cheap & Best with original Photos
 
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Jayanagar Just Call 7001305949 Top Class Call Girl Service Available
 
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
Air-Hostess Call Girls Madambakkam - Phone No 7001305949 For Ultimate Sexual ...
 
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls ServiceCall Girls Thane Just Call 9910780858 Get High Class Call Girls Service
Call Girls Thane Just Call 9910780858 Get High Class Call Girls Service
 
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hebbal Just Call 7001305949 Top Class Call Girl Service Available
 
97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA97111 47426 Call Girls In Delhi MUNIRKAA
97111 47426 Call Girls In Delhi MUNIRKAA
 
Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.Statistical modeling in pharmaceutical research and development.
Statistical modeling in pharmaceutical research and development.
 
Case Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptxCase Report Peripartum Cardiomyopathy.pptx
Case Report Peripartum Cardiomyopathy.pptx
 
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
call girls in paharganj DELHI 🔝 >༒9540349809 🔝 genuine Escort Service 🔝✔️✔️
 
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service AvailableCall Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
Call Girls Hsr Layout Just Call 7001305949 Top Class Call Girl Service Available
 
Glomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptxGlomerular Filtration rate and its determinants.pptx
Glomerular Filtration rate and its determinants.pptx
 
Glomerular Filtration and determinants of glomerular filtration .pptx
Glomerular Filtration and  determinants of glomerular filtration .pptxGlomerular Filtration and  determinants of glomerular filtration .pptx
Glomerular Filtration and determinants of glomerular filtration .pptx
 
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
Call Girls Electronic City Just Call 7001305949 Top Class Call Girl Service A...
 
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
Russian Call Girls Chickpet - 7001305949 Booking and charges genuine rate for...
 
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call NowKolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
Kolkata Call Girls Services 9907093804 @24x7 High Class Babes Here Call Now
 

Computer System Validation

  • 1. This presentation is compiled by “ Drug Regulations” a non profit organization which provides free online resource to the Pharmaceutical Professional. Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals. 1/9/2014 1
  • 2. This presentation is compiled from freely available resources like the websites of FDA, EMA, WHO.  “Drug Regulations” is a non profit organization which provides free online resource to the Pharmaceutical Professional.  Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals.  Drug Regulations : Online Resource for Latest Information 1/9/2014 2
  • 3.  This presentation describes approaches for software validation used to automate laboratory research procedures, consolidate data collection and analysis and/or run sophisticated QC or manufacturing operations.  Several approaches to software validation exist and may be appropriate for a specific project.  The scope of any validation effort depends upon a number of factors   Origin of the software (custom vs. off-the-shelf) and   Size and complexity of the software, Whether the functions are critical or non-critical in nature. By effectively planning the process, validation time and resources can be reduced while meeting regulatory requirements. Drug Regulations : Online Resource for Latest Information 1/9/2014 3
  • 4.  When equipment breaks, there are typically obvious and immediate symptoms. Catastrophic results can often be avoided  Computer system defects can typically be very difficult to recognise and severe problems may result without being detected until well after the problem started  Drug companies, the airline industry, public utilities, nuclear power plants and other industries where quality is critical have seen very expensive consequences from improper computer system operation  Many of these consequences cost far more than the cost of Computer Validation Drug Regulations : Online Resource for Latest Information 1/9/2014 4
  • 5.  Significant increase in the use of computer- related systems in the Life Sciences industries.  These systems must satisfy cGMP requirements  Legitimate questions have been raised concerning the scope and methods which should be employed in validations. Drug Regulations : Online Resource for Latest Information 1/9/2014 5
  • 6.  Responsibility of the end-user to assure that systems used are in compliance with applicable regulations.  Many users rely too heavily upon vendorsupplied information and test data to support their system validation. Drug Regulations : Online Resource for Latest Information 1/9/2014 6
  • 7.  The extent of testing and the type of documentation required to support validation is unclear  Difficult to delineate vendor and user responsibilities when validating vendor-supplied systems.  Validation of computer-related systems is often complex, and any number of alternate approaches can be utilized. Drug Regulations : Online Resource for Latest Information 1/9/2014 7
  • 8. In general, a combination of hardware, software, people, documents, inputs, processing, and outputs working together Inputs Software Hardware Controlling System Controlled process outputs Equipment Operating Procedures & Documentation People and Training Drug Regulations : Online Resource for Latest Information
  • 9. • MRP/ERP system? • LIMS system? • Laboratory Instruments (e.g. Chromatography)? • Automated manufacturing or packaging equipment? • IT systems, including those supporting network and infrastructure? • Spreadsheets or databases? Drug Regulations : Online Resource for Latest Information 1/9/2014 9
  • 10.  FDA approach is based on three main elements: (Guidance) ◦ Part 11 will be interpreted narrowly ◦ Fewer records subject to part 11 ◦ For those records that remain subject to part 11, FDA intends to exercise enforcement discretion with regard to part 11 requirements for  Validation  Audit trails  Record retention  Record copying  Systems that were operational before the effective date of part 11 (also known as legacy systems) ◦ FDA will enforce all predicate rule requirements, including predicate rule record and recordkeeping requirements. Drug Regulations : Online Resource for Latest Information 1/9/2014 10
  • 11.  FDA's exercise of enforcement discretion as described in this guidance is limited to specified part 11 requirements  FDA intends to enforce all other provisions of part 11 including, but not limited to, certain controls for closed systems in § 11.10. ◦ For example, FDA intends to enforce provisions related to the following controls and requirements: Drug Regulations : Online Resource for Latest Information 1/9/2014 11
  • 12. ◦ Limiting system access to authorized individuals ◦ Use of operational system checks ◦ Use of authority checks ◦ Use of device checks ◦ Determination that persons who develop, maintain, or use electronic systems have the education, training, and experience to perform their assigned tasks Drug Regulations : Online Resource for Latest Information 1/9/2014 12
  • 13. ◦ Appropriate controls over systems documentation ◦ Controls for open systems corresponding to controls for closed systems bulleted above (§ 11.30) ◦ Requirements related to electronic signatures  (e.g., §§ 11.50, 11.70, 11.100, 11.200, and 11.300) Drug Regulations : Online Resource for Latest Information 1/9/2014 13
  • 14. ◦ FDA intends to exercise enforcement discretion regarding specific part 11 requirements for validation of computerized systems (§ 11.10(a) and corresponding requirements in § 11.30). Drug Regulations : Online Resource for Latest Information 1/9/2014 14
  • 15. ◦ Take into account the impact the systems have on ability to meet predicate rule requirements. ◦ Consider the impact those systems might have on the accuracy, reliability, integrity, availability, and authenticity of required records and signatures. ◦ Even if there is no predicate rule requirement to validate a system, in some instances it may still be important to validate the system. Drug Regulations : Online Resource for Latest Information 1/9/2014 15
  • 16. ◦ Base validation approach on  A justified and documented risk assessment  A determination of the potential of the system to affect product quality and safety, and record integrity. ◦ Validation would not be important for a word processor used only to generate SOPs. Drug Regulations : Online Resource for Latest Information 1/9/2014 16
  • 17.  Audit Trails ◦ Enforcement discretion related to computer-generated, timestamped audit trails (§ 11.10 (e), (k)(2) and any corresponding requirement in §11.30). ◦ Also comply with all applicable predicate rule requirements related to documentation  Date (e.g., § 58.130(e))  Time, or sequencing of events  Requirements for ensuring that changes to records do not obscure previous entries Drug Regulations : Online Resource for Latest Information 1/9/2014 17
  • 18.  Audit Trails ◦ Have them even if there are no predicate rule requirements  (for date, time, or sequence of events) ◦ Alternatively have other physical, logical, or procedural security measures in place. Drug Regulations : Online Resource for Latest Information 1/9/2014 18
  • 19.  Audit Trails ◦ Base your decision on  The need to comply with predicate rule requirements  A justified and documented risk assessment  A determination of the potential effect on product quality and safety and record integrity Drug Regulations : Online Resource for Latest Information 1/9/2014 19
  • 20.  Audit Trails ◦ Apply appropriate controls based on such an assessment. ◦ Audit trails appropriate when records are  Created  Modified  Deleted Drug Regulations : Online Resource for Latest Information 1/9/2014 20
  • 21.  Legacy Systems ◦ FDA to exercise enforcement discretion for systems that otherwise were operational prior to August 20, 1997 ◦ FDA not to take enforcement action if all the following criteria are met for a specific system: Drug Regulations : Online Resource for Latest Information 1/9/2014 21
  • 22.  Legacy Systems …..contd ◦ The system was operational before the effective date. ◦ The system met all applicable predicate rule requirements before the effective date. ◦ The system currently meets all applicable predicate rule requirements. ◦ You have documented evidence and justification that the system is fit for its intended use (including having an acceptable level of record security and integrity, if applicable). Drug Regulations : Online Resource for Latest Information 1/9/2014 22
  • 23.  Applies to all forms of computerised systems used as part of a GMP regulated activities.  A computerised system is a set of software and hardware components which together fulfil certain functionalities.  The application should be validated;  IT infrastructure should be qualified.  Where a computerised system replaces a manual operation, there should be no resultant decrease in product quality, process control or quality assurance.  There should be no increase in the overall risk of the process. Drug Regulations : Online Resource for Latest Information 1/9/2014 23
  • 24.  Validation ◦ Documentation and reports should  Cover life cycle.  Include change control  Deviations during validation process ◦ Justify standards, protocols, acceptance criteria, procedures and records based on their risk assessment. Drug Regulations : Online Resource for Latest Information 1/9/2014 24
  • 25.  Validation ◦ List all relevant systems and their GMP functionality ◦ For critical systems prepare  System description  Physical and logical arrangements  Data flows  Interfaces with other systems or processes  Hardware and software pre-requisites  Security measures Drug Regulations : Online Resource for Latest Information 1/9/2014 25
  • 26.  Validation ◦ Prepare user requirements Specifications  Describe the required functions  Base it on documented risk assessment and GMP impact  Make it traceable throughout the life-cycle Drug Regulations : Online Resource for Latest Information 1/9/2014 26
  • 27.  Validation ◦ Ensure that the system has been developed in accordance with Q M S ◦ Assess the supplier appropriately ◦ Ensure formal assessment and reporting of quality & performance measures of bespoke or customised computerised systems for life cycle. Drug Regulations : Online Resource for Latest Information 1/9/2014 27
  • 28.  Validation ◦ Demonstrate evidence of appropriate test methods and test scenarios  System (process) parameter limits  Data limits  Error handling ◦ Document adequacy of Automated testing tools and test environments. Drug Regulations : Online Resource for Latest Information 1/9/2014 28
  • 29.  Validation ◦ If data are transferred to another data format or system, validation should include checks that data are not altered in value and/or meaning during this migration process. Drug Regulations : Online Resource for Latest Information 1/9/2014 29
  • 30. New Computer System Existing Computer System Def inesy stem Function Structure Def ine Sof tware Def inesy stem Function Structure Design/Specif y hardware Qualif y Sy stem Dev elop Sof tware I ns t all hardware Rev iew operating experience Verif y Sof tware Qualif y hardware Test Indiv idual Modules (Computer Sy stem) Data Integrate ComputerizedSy stem Dataanaly sis Test Integrated modules (Computerized Sy stem) Validation Acceptance Demonstratetotal sy stem operation (Computer-Related Sy stem) Ongoings y s t em ev aluat ion Change Conduct sy stem testing (if needed) F ileD oc um ent at ion 1/9/2014 30
  • 31.  Users play a key validation role in:  Starting the process for new or existing systems  Performing some major steps (e.g. Requirements)  Writing and following operating procedure  Maintaining the validated state while in use  Developers play a key role in many steps including:  Design, coding, testing, changes, support  Support groups (IT, IR, SCS, Infrastructure):  Maintain proper network environment  Troubleshooting and maintenance  Desktop and infrastructure control Drug Regulations : Online Resource for Latest Information 1/9/2014 31
  • 32.  QA and Validation Author some major documents Approve major documents that others write Provide advice, training, auditing  Senior management for each group decides: Which systems to buy or build How much resource to make available What risks are acceptable Drug Regulations : Online Resource for Latest Information 1/9/2014 32
  • 33. Incorporate multi-functional participation  ◦ Management Information Systems ◦ Developers ◦ Vendors ◦ Consultants ◦ Software QA ◦ Executive Management Drug Regulations : Online Resource for Latest Information 1/9/2014 33
  • 34. Responsibilities  ◦ Definition ◦ Planning ◦ Risk Assessment ◦ Evaluation of intended use ◦ Execution ◦ Documentation ◦ Review ◦ Approval Drug Regulations : Online Resource for Latest Information 1/9/2014 34
  • 35.  Have a combination of skill sets in the team  Include individuals who are experienced with ◦ Regulations ◦ Validation approaches ◦ Systems ◦ Processes ◦ Intended users Drug Regulations : Online Resource for Latest Information 1/9/2014 35
  • 36. The level of documentation required depends on  ◦ Complexity and intended use of the system; ◦ Origin of the software/system (vendor supplied or developed internally). ◦ Examples of documentation required to support validation: Drug Regulations : Online Resource for Latest Information 1/9/2014 36
  • 37.  Validation SOPs and Policies  Project Management Plan  Validation Plan  Traceability Analysis  Risk (Hazard) Management  System Topology and  Specification and Documents Plan  Computerized System Design Installation Summaries Configuration Management  Plan Validation Protocols / Test Case Procedures  Change Management Plan  IQ/OQ/PQ Reports  System Test Plans  Validation Reports  Computer-Related System Requirements Specification Drug Regulations : Online Resource for Latest Information 1/9/2014 37
  • 38. 1. PLAN Validation Activities 4. DESIGN & REVIEW 5. CONSTRUCT & TEST 2. DEFINE 6. INTEGRATE/INSTALL Requirements 7. QUALIFY 8. EVALUATE 3. SELECT Computerized System Vendors Drug Regulations : Online Resource for Latest Information
  • 39.  Write and approve validation policies  Write specific SOPs for validation of Computer Systems  Develop protocols  Review test data  Write summary reports to assure the validation objectives are met  Use validation Project Plan to  Identify the systems to be included  Procedures to be followed  Timeline for a specific validation project Drug Regulations : Online Resource for Latest Information 1/9/2014 39
  • 40.  Project resources and budget requirements  Validation Project Plan for  Single system,  Combination of systems  Entire facility.  Establish specific responsibilities  Establish expectations for each validation activity Drug Regulations : Online Resource for Latest Information 1/9/2014 40
  • 41.  Create a document of high level goals of validation  Specify “what” at a high level should be accomplished by the CSV  Review available documentation  Conduct interviews with users  Map existing processes Drug Regulations : Online Resource for Latest Information 1/9/2014 41
  • 42.  Initial focus on  Functionality  Operational and performance parameters  Overall objectives for the validation effort  Specify the requirement in detail to support testing that requirement and defining acceptance criteria.  Trace back protocols to each requirement  via a Traceability Matrix Drug Regulations : Online Resource for Latest Information 1/9/2014 42
  • 43.  Requirements traceable to Functional Specifications and testing  Unambiguous, clear, concise  Testable and measurable  Typically written and approved by end-user  Basis for system acceptance testing  Should be approved before the design review Drug Regulations : Online Resource for Latest Information 1/9/2014 43
  • 44.  The highest level design document responding directly to the User Requirements Specification  All system inputs, outputs, and interfaces  All functions and performance requirements  Error definition and handling  Ranges, limits, defaults  Safety considerations Drug Regulations : Online Resource for Latest Information 1/9/2014 44
  • 45.  Internal development group or an outside company.  Consider vendor‟s ability to provide a system which can be validated  Selection Criteria  Technical competency  Qualified to supply  Support for the proposed system  Knowledge of validation requirements  Experience in providing systems for cGMP applications Drug Regulations : Online Resource for Latest Information 1/9/2014 45
  • 46.  Type of software being evaluated  Type hardware being evaluated  For off-the-shelf software and standard hardware  History of customer satisfaction is of importance  For custom developed systems  Vendor‟s Quality Assurance System Drug Regulations : Online Resource for Latest Information 1/9/2014 46
  • 47. Primary Responsibility for Specification Primary Responsibility for Testing Testing of the URS More User involvement for custom systems, less for packaged Supplier Functional Specification Performance Qualification Testing of the Functional Specification Design Specification Testing of the Operation Qualification Installation Qualification Design Specification Build System Design Specification Unit Testing Requirement Specification System Testing Drug Regulations : Online Resource for Latest Information User More Supplier involvement for custom systems, less for packaged User Requirements Specification User Supplier
  • 48.  Computerized System Design Specification  Document or a collection of documents  Describes clearly and completely  How the computerized system will Operate  Satisfy Computer-Related System Requirements Specification  Both normal and abnormal operating conditions  Information about the interfaces between the computerized system and its operating environment Drug Regulations : Online Resource for Latest Information 1/9/2014 48
  • 49.  Applies to both the computer system and the controlled function/process  joint responsibility of the vendor and user.  Interfaces between the computerized system and its operating environment.  The Design Specification can not be developed until the vendors and the specific hardware and software have been selected. Drug Regulations : Online Resource for Latest Information 1/9/2014 49
  • 50.  Defines how the system should meet the requirements, including…  Architecture AND interfaces  All functions  Data processing and integrity  Security  Backup, archive, and restoration  disaster recovery  Data definition Drug Regulations : Online Resource for Latest Information 1/9/2014 50
  • 51.  Activity performed to verify that all deliverables from Requirements and Design Phases are produced and…  are clear and concise  are complete, current, and traceable  electronic record and signatures addressed  are testable  show system fit for purpose Drug Regulations : Online Resource for Latest Information 1/9/2014 51
  • 52.  Complete Design Review before starting  Perform in accordance with written Programming Standards  Programming Standards should define appropriate rules for writing source code (e.g. dead code, structure, naming) Drug Regulations : Online Resource for Latest Information 1/9/2014 52
  • 53.  The computerized system may be constructed by developing custom software and hardware for the application - or purchasing established products - or a combination of both.  From a validation perspective, custom developed software and hardware require the greatest amount of testing since they have never been proven effective. Drug Regulations : Online Resource for Latest Information 1/9/2014 53
  • 54.  Three categories of software can be defined:  System software  Configurable software  Application specific software Drug Regulations : Online Resource for Latest Information 1/9/2014 54
  • 55. GAMP Classification No GAMP 4 GAMP 5 1 Operating Systems Infrastructure Software 2 Firmware No longer used 3 Standard Software Packages Non configured Products 4 Configurable Software Packages Configured Products 5 Custom (bespoke) Software Custom Applications Drug Regulations : Online Resource for Latest Information 1/9/2014 55
  • 56.  These categories are not intended to be rigid but they allow distinctions to be made so that validation approaches are appropriate. Drug Regulations : Online Resource for Latest Information 1/9/2014 56
  • 57.  Efficient Environment  Defined processes  Assigned responsibilities  Planned audits  Structured reviews  Management controls Drug Regulations : Online Resource for Latest Information 1/9/2014 57
  • 58.  Should be completed before formal testing  Verify code complies with Programming Standards  Check to ensure all pre-defined system specifications are addressed  Check for coding errors Drug Regulations : Online Resource for Latest Information 1/9/2014 58
  • 59. „White Box‟ * ● Unit Testing/Structural Testing ● Low level out in „Black Box‟ * ● System & Acceptance testing ● Functional Testing ● Higher level in out Manual Calculation Drug Regulations : Online Resource for Latest Information
  • 60.  Define and justify the how the system will be tested and how much  Address how tests are traceable to specifications  Testing approach should address  Normal operation  Entire design range, boundaries, stress  Failure modes, including power failure  Should be approved before testing starts Drug Regulations : Online Resource for Latest Information 1/9/2014 60
  • 61.  Lists the test objective  Traceable to specifications  Lists test pre-requisites  Reproducible test steps  Clear acceptance criteria Drug Regulations : Online Resource for Latest Information 1/9/2014 61
  • 62.  Record all raw data and derived results  Ticks, „ok‟, „yes/no‟, „Pass/Fail‟ or similar are not valid results  Record a „Pass/Fail‟ conclusion of whether results met acceptance criteria  Signature and date of test performer  Signature and date of test result approver  References to incident log for failures Drug Regulations : Online Resource for Latest Information 1/9/2014 62
  • 63.  Used to…  Collate test result documentation  Conclude each phase of testing  Authorise subsequent testing phases  Summarises the testing outcome, addresses test failures Drug Regulations : Online Resource for Latest Information 1/9/2014 63
  • 64.  Unit Testing  Focuses verification effort on the smallest unit of software design – the software component or module  Integration Testing  “If they all work individually, why do you doubt that they‟ll work when we put them together?”  The problem is “putting them together” – interfacing  Data may be lost  One module can have an inadvertent, adverse effect on another; sub-function when combined  Global data structure can present problems Drug Regulations : Online Resource for Latest Information 1/9/2014 64
  • 65.  Regression Testing  Each time a new module is added as part of integration testing, the software changes  New data flow paths are established  New I/O and control logic is invoked  Regression testing is the re-execution of some subset of tests that have already been conducted to ensure that changes have not propagated unintended side effects Drug Regulations : Online Resource for Latest Information 1/9/2014 65
  • 66.  Smoke testing  An integration testing  Software components that have been translated into code are integrated into a “build” – data files, libraries, reusable modules, and engineered components that are required to implement one or more product  The intent of testing here is to uncover show stoppers – errors that have the highest likelihood of throwing the software project behind schedule  The build is integrated with other builds and the entire product is smoke tested daily Drug Regulations : Online Resource for Latest Information 1/9/2014 66
  • 67.  Unit Testing    An encapsulated class is the focus of unit testing Operations within the class are, however, the smallest unit Integration Testing  Thread based testing  Integrates a set of classes required to respond to one input or event for the system  Used based testing  Begins the construction of the system by testing independent classes – use very few if any server classes  Testing dependent classes – which use independent classes Drug Regulations : Online Resource for Latest Information 1/9/2014 67
  • 68.  Integration Testing  Cluster Testing  A cluster of collaborating classes (determined by examining the CRC) to uncover errors in collaboration Drug Regulations : Online Resource for Latest Information 1/9/2014 68
  • 69.  Proper integration, installation and commissioning of a computerized system is essential to the successful qualification of the system.  A packaged system may be integrated at the vendors site  More complex systems may be integrated at the users site Drug Regulations : Online Resource for Latest Information 1/9/2014 69
  • 70.  Data Load  Operational and Support Plans (e.g. SOP, training, service contracts, security, support processes)  Specify procedures employed in the Validation Plan.  Specify responsibility for all tasks in the Validation Plan.  Demonstrate proper installation of hardware & software in Installation Qualification (IQ) Drug Regulations : Online Resource for Latest Information 1/9/2014 70
  • 71.  Qualification is a procedure of testing and collecting data to provide a high level of assurance that a computerized system operates in accordance with the system specification.  Write & approve protocols in advance  Protocols should specify the following  Goals of testing  Test methods  Acceptance criteria  Who is responsible for testing Drug Regulations : Online Resource for Latest Information 1/9/2014 71
  • 72.  IQ (Installation Qualification) verifies that all aspects of installing hardware and software meet specifications and that user manuals, SOP‟s and backup procedures are in place.  OQ (Operational Qualification) verifies that the system operates throughout its anticipated ranges according to its specifications and identifies all important parameters. Drug Regulations : Online Resource for Latest Information 1/9/2014 72
  • 73.  PQ (Performance Qualification) verifies that a system performs its intended function in accordance with its specifications.  Testing is completed on the entire system while operating in its normal environment. Drug Regulations : Online Resource for Latest Information 1/9/2014 73
  • 74.  In order to assure that the system remains in a validated state, Performance Monitoring is required to continually test a system‟s performance in executing defined processes:  Periodic calibration and maintenance  Continuous monitoring of critical parameters  Confirmation of security measures  Provisions for contingency planning, disaster recovery and personnel training  Change Control procedures must be established to keep a CRS in a validated state during planned and unplanned changes. Drug Regulations : Online Resource for Latest Information 1/9/2014 74
  • 75. Summary: Validation requirements for Software Programme overrides Edits, input manipulation Language Name, function Software identification Fixed and Variable Set points Input, output Drug Regulations : Online Resource for Latest Information
  • 76. Summary: Validation requirements for Software Key aspects Software development Software security Drug Regulations : Online Resource for Latest Information
  • 77. Summary: Validation requirements for Software Function Worst case Documentation Validation Revalidation Repeats Drug Regulations : Online Resource for Latest Information
  • 78.  This presentation was compiled from freely available resources like the websites of FDA, EMA, WHO.  “Drug Regulations” is a non profit organization which provides free online resource to the Pharmaceutical Professional.  Visit http://www.drugregulations.org for latest information from the world of Pharmaceuticals. Drug Regulations : Online Resource for Latest Information 1/9/2014 78